StockWatch
·
Biotechnology: Pharmaceutical Preparations
Loan & DebtJun 18, 2026, 05:21 PM

Jaguar Health Amends Debt Agreements, Extends Payment Dates

AI Summary

Jaguar Health, Inc. has entered into several amendments and exchange agreements primarily with Streeterville Capital, LLC and Uptown Capital, LLC. Key changes include amendments to royalty interest agreements, extending the initiation of monthly royalty payments to October 1, 2026, with a minimum payment of $750,000. Additionally, the maturity date of a $6.22 million promissory note with Streeterville has been extended to October 1, 2026. The company also completed three exchange transactions with Streeterville, issuing a total of 110,249 shares of common stock in exchange for shares of Series Q Preferred Stock.

Key Highlights

  • Jaguar Health amended royalty interest agreements with Uptown Capital and Streeterville Capital, extending monthly payment initiation to October 1, 2026.
  • Monthly royalty payments will be the greater of $750,000 or the actual amount due, starting October 1, 2026.
  • Jaguar Health extended the maturity date of a $6.22 million secured promissory note with Streeterville from July 1, 2026, to October 1, 2026.
  • Jaguar Health exchanged 3.8 shares of Series Q Preferred Stock for 34,798 shares of Common Stock with Streeterville on June 9, 2026.
  • Jaguar Health exchanged 3.4 shares of Series Q Preferred Stock for 36,796 shares of Common Stock with Streeterville on June 17, 2026.
  • Jaguar Health exchanged 3.68 shares of Series Q Preferred Stock for 38,655 shares of Common Stock with Streeterville on June 18, 2026.